# Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ)

> **NCT00525785** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 58 (actual)

## Conditions studied

- Stomach Cancer
- Gastric Cancer

## Interventions

- **DRUG:** 5-Fluorouracil
- **DRUG:** Folinic Acid
- **DRUG:** Oxaliplatin
- **RADIATION:** Radiotherapy
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT00525785
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2020-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00525785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00525785, "Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00525785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*